Design and structure–activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases
摘要:
-3-Benzimidazol-2-yl-1H-indazole analogs were developed as inhibitors of receptor tyrosine kinases (RTK). The synthesis and SAR of this series is reported. (c) 2006 Elsevier Ltd. All rights reserved.
3-Benzimidazol-2-yl-1H-indazoles as potent c-ABL inhibitors
摘要:
The 3-benzimidazol-2-yl-1H-indazole scaffold was developed as an alternate scaffold for our receptor tyrosine kinase (RTK) inhibitor program. In exploring the SAR of this series, it was discovered that a subset of these compounds potently inhibit the enzyme c-ABL. The SAR of these compounds is described. (c) 2006 Elsevier Ltd. All rights reserved.
Design and structure–activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases
作者:Christopher M. McBride、Paul A. Renhowe、Carla Heise、Johanna M. Jansen、Gena Lapointe、Sylvia Ma、Ramon Piñeda、Jayesh Vora、Marion Wiesmann、Cynthia M. Shafer
DOI:10.1016/j.bmcl.2006.03.069
日期:2006.7
-3-Benzimidazol-2-yl-1H-indazole analogs were developed as inhibitors of receptor tyrosine kinases (RTK). The synthesis and SAR of this series is reported. (c) 2006 Elsevier Ltd. All rights reserved.
US7642278B2
申请人:——
公开号:US7642278B2
公开(公告)日:2010-01-05
3-Benzimidazol-2-yl-1H-indazoles as potent c-ABL inhibitors
作者:Christopher M. McBride、Paul A. Renhowe、Thomas G. Gesner、Johanna M. Jansen、Julie Lin、Sylvia Ma、Yasheen Zhou、Cynthia M. Shafer
DOI:10.1016/j.bmcl.2006.04.043
日期:2006.7
The 3-benzimidazol-2-yl-1H-indazole scaffold was developed as an alternate scaffold for our receptor tyrosine kinase (RTK) inhibitor program. In exploring the SAR of this series, it was discovered that a subset of these compounds potently inhibit the enzyme c-ABL. The SAR of these compounds is described. (c) 2006 Elsevier Ltd. All rights reserved.